Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00037869
Status:
COMPLETED
Last Update Posted:
2018-10-31
First Post:
2002-05-24
Brief Title:
High Dose I-131 MetaiodobenzylguanidineMIBG for Metastatic Neuroendocrine Tumors
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-11
Start Date Type:
None
Primary Completion Date:
2005-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-01
Completion Date Type:
ACTUAL
First Submit Date:
2002-05-24
First Submit QC Date:
May 24 2002
Study First Post Date:
2002-05-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-30
Last Update Post Date:
2018-10-31
Last Update Post Date Type:
ACTUAL